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This research review is endeavoring to shed the light on the cause and effect of 
Chronic Venous Ulcer (CVU) in line with its therapeutic procedures. In the last two 
decades, a lot of the changes occurred in strategy of wound management through 
developing adjunctive therapy that supported wound healing. Eventually, the latest 
development was in platelet concentration technology produced the platelet-rich 
fibrin (PRF). It was categorized as the 2nd generation of platelet concentration 
family after Platelet Rich Plasma (PRP). Considering that Venous Leg Ulcers 
(VLUs) accounted for 70% of all leg ulcers and estimated one percent of the popu-
lation where age as an essential factor has increased its prevalence. The chronicity 
and refractory nature of venous ulcer had a great effect on the quality of life and 
work productivity of patients apart from, the expenditure of significant amount of 
medical resources and efforts. Therefore, the ultimate goal of (VLU) management 
was to induce a rapid healing without recurrence which mainly helped to improve 
the quality of life (QoL). The first therapeutic procedure used in treatment of VLU 
was compression therapy where the application of effective graduated compres-
sion decreased the overload in venous system and venous reflux. Furthermore, it 
accelerated the capillary of blood flow and decreased the capillary of fluid leakage 
which in return alleviated the limb edema.
Keywords: Venous ulcer, Ambulatory venous hypertension, Chronic venous 
insufficiency, Compression therapy, Platelet rich fibrin
1. Introduction
Chronic leg ulcers (CLUs) defined as a chronic wound that does not show 
tendency of healing within reasonable period, this period can determine the state 
of being chronic wound or not as if there is no tendency of healing after 3 months 
or not fully healed after 12 months, it will be named as chronic ulcer [1]. The fore 
mentioned period is not a fixed number it is governed by other factors such as ulcer 
ethology, size and other factors [2].
In general ulcer can be described in many different ways for instance, it has a full 
thickness wound, it lacks a source of re epithelization in the center, and it shows a 
low tendency of healing.
The most common clinical cause of CLUs is venous insufficiency then arterial 
insufficiency, diabetes or a combination of two or more of this factors [3].
The Wound Healing Society described the chronic wound as “a silent epidemic 
disorder” correlated to percentage of public had this condition. In the US, as an 
approximate number of 6.5 million patients suffered from chronic non healed 
wounds. Therefore, two million of working days lost annually. In addition, in 




Venous insufficiency considered as the most common cause of the leg ulcers 
with a percentage of 70%. Inline arterial diseases, mixed venous & arterial disor-
ders represent 10% and 15% respectively. There is a big challenge in assessment 
and diagnosis for CLU where it comes to having miscellaneous disorders such as 
vasculitis, hematological diseases. This kind of disorders represents the last 5% of 
the causes of CLUs [5].
Scottish Guidelines defined the chronic venous leg ulcer as “an open lesion 
between the knee and the ankle joint that remains unhealed for at least four weeks and 
occurs in the presence of venous disease” [6].
2. Anatomy of venous system in lower limb
The anatomical variation and nonuniform nomenclature of lower limb veins 
system especial in literatures were supported the constitution of International 
Interdisciplinary Committee at 2001 to did adjustment and uniform the anatomical 
terminology of lower limb veins (Figure 1) [7].
The veins of lower limb can be classified into three systems, superficial, deep 
and perforators veins. These veins are arranged into two main compartments; 
superficial and deep compartments. Superficial compartment is presented between 
the skin and muscular fascia which contain the superficial veins, On the other hand, 
deep compartment that contain the deep veins is presented under the deep fascia. 
The perforator veins are connected the superficial and deep system [9]. Ultrasound 
image shows there is other compartment within the superficial compartment 
enclosing the saphenous vein named a saphenous compartment (Figures 2 and 3).
The principle way for venous return from lower limb is through the deep vein 
system which paired below the knee and accompany to arteries then joined to form 
popliteal vein that complete ascending as femoral vein. The main veins in super-
ficial system that target for a lot of venous therapy are the great saphenous vein 
Figure 1. 




and small saphenous vein, these veins are connected together with communicator 
veins difference to perforator veins that connect the superficial and deep system by 
perforating the muscular fascia [10].
The perforator veins have normal unidirectional flow from superficial to deep 
system and there are more than 150 perforators in lower extremity but most of them 
are inactive in normal state. Perforator veins on medial aspect of leg represent the 
most clinical important perforators in chronic veins insufficiency [11].
Valve of lower extremity veins is one of anatomical feature that has clinical 
important in case of incompetence of these valves transmission of venous pressure 
to skin venules and development of skin changes [12].
3. Physiology of lower limb venous system
Venous system offers the most important function to support circulation by 








Schematic summarization of relationship between pressure & volume in lower extremity with walking and 
standing position. Note the efficacy of calf muscle pumping mechanism that lead to drop of venous volume and 
pressure with walking and slight delay in raising of venous pressure opposite to venous blood volume at standing 
position. Alternation in this relationship resulting in high ambulatory venous pressure.
(25% in splanchnic network & other residual volume in post capillary venules). 
Therefore, the venous return must be equals to cardiac output to keep homeostasis 
of tissue perfusion [13]. There are many factors had a role in venous return mecha-
nism such as: central pump, pressure gradient, venous valves and muscle pumps 
(peripheral pump) [8].
Venous valves distributed meanly in distal vein circulation of lower limb to 
overcome the effect of gravity and breakdown the hydrostatic pressure of blood 
column into segments, the closure of valve is passive mechanism by gradient pres-
sure difference between supra & infra valvular segment and normal retrograde flow 
that last for less than 0.5 sec. That enough for closure of cusps completely [12].
Calf muscles contraction (gastrocnemius and soleus) constitute primary essen-
tial part in mechanism of venous return, it has estimated an approximately 60% 
of venous return from lower limb depended on ejection force of calf muscle. The 
net result of serial contraction of calf muscle during exercise produces stream line 
and unidirectional of blood in deep venous system toward the heart and improves 
cardiac output [12].
Efficacy of calf muscle pump is depended on strength of muscle, range of move-
ment of ankle joint and competent of vein valves. Hypothesis the atrophy of calf 
muscle decreases the strength of contraction result in reduction of venous return 





Accumulation of blood in peripheral venous circulation during rest leads to 
elevation of venous pressure especially with standing position while contraction 
of the calf muscle will decrease the venous pressure to be suitable base line. The 
measuring of drop in superficial venous system pressure after exercise called ambu-
latory venous pressure (AVP) which is indicator for calf muscle pump function and it 
is elevation above 30 mm Hg has linear relationship with leg ulcer (Figure 4) [15].
4. Pathophysiology of venous ulcer
The pathophysiology behind chronic leg venous ulcers is still unclear. 
Ambulatory venous hypertension (AVH) is considered to be the essential pathological 
factor behind venous ulcer. Venous incompetence can be resulted from immobility, 
ineffective pumping mechanism of the calf muscles and venous valves dysfunction. 
In addition, venous valves dysfunction that is resulted from venous thrombosis, 
phlebitis or trauma will lead to alternation in venous hemodynamic and precipitate 
venous hypertension [16].
Subsequently, chronic blood stasis of lower limb venous system causes further 
capillary damage with inflammatory process activation. Leukocyte activation, 
endothelial damage, platelet aggregation, and intracellular edema highly related to 
venous ulcer development and impaired wound healing [17].
4.1 Ambulatory venous hypertension
Calf muscle pump consists of calf muscle, superficial venous system, deep 
venous system and perforators that connect both systems. The out flow vein of 
this pump is popliteal vein. Failure of calf muscle pump to decrease AVP leads to 
persistent elevation of post exercise pressure that referred to as ambulatory venous 
hypertension (AVH) [15].
Therefore, one or more of the following pathological situations can lead to calf 
muscle pump dysfunction and AVH:
4.1.1 Reflux in superficial veins system
The cause behind the reflux or incompetent valve in superficial veins is still 
ambiguous. Currently there is a discussion on congenital and acquired factors that 
may be behind the structure changes in valve cusp.
The reflux in superficial veins can be compensated with calf muscle contrac-
tion if perforator valves are competent, Secondary incompetent valve of deep and 
perforator veins likely to occur with large volume reflux post sapheno-femoral or 
sapheno-popliteal incompetence [12].
4.1.2 Reflux/obstruction in deep veins system
The Post thrombotic damage of deep veins will result in obstruction, reflux or 
both and even can lead to reflux in superficial & perforator veins later (post throm-
botic syndrome) [12].
4.1.3 Incompetent medial calf perforator
If out ward flow of incompetent perforators more than 500 milliseconds and 
equal to or more than 3.5 millimeter in size will have significant hemodynamic 
effect as high AVH and skin changes [12].
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Muscular dysfunction of calf muscle, fixed ankle joint and prolonged immobili-
zation will lead to blood stasis and venous hypertension as a result of pump mecha-
nism failure [18]. In clinical practice, these pathologies presented in combination 
with multilevel involvement in large group of patients.
4.2 Chronic Venous Disorder &Chronic Venous Insufficiency
According to updated terminology of chronic venous disorders in the VEIN-
TERM transatlantic interdisciplinary consensus document, chronic venous disorder 
(CVD) defined as a wide spectrum of functional and morphological abnormality 
that involves veins system from telangiectasia to venous ulcers (C1- C6 Clinical 
classes). Chronic venous insufficiency (CVI) term reserved for advanced CVD (C3-
C6 clinical classes) that include moderate to severe edema, skin changes or venous 
ulcer [19].
CVI classified into two types:
Primary chronic venous insufficiency: occur due to weakness or degenerative 
changes in wall or venous valves which started as reflux in superficial veins and 
Clinical class
C0 No venous disease
C1 Spider Angioma
C2 Varicose veins
C3 Edema of venous etiology




*Each clinical class is further sub classed as “S” if symptomatic & “A” if asymptomatic
* The symptoms include aching, pain, tightness, skin irritation, heaviness, muscle cramps, and other 
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proceed to perforators and deep veins later due to overload that lead to dilatation in 
the venous wall [20].
Secondary chronic venous insufficiency: known as post thrombotic syndrome, it 
is secondary to acute DVT and later sequelae that can be lead to reflux, obstruction 
or both in deep veins. As well as, it could be secondary to superficial thrombophle-
bitis, or arteriovenous fistula [19].
4.3 Revised CEAP classification of chronic venous disorders (CVD)
The need for clinical assessment, evaluation and stage identification method 
of CVD supported to present of CEAP classification on American Venous Forum 
annual meeting 1994 and revised on 2004 [21].
CEAP classification is a method for classification of CVD based on:
Clinical manifestations.
Ethological factors.
Anatomical distribution of disease.
Pathophysiological process behind this disorder (Table 1).
5. Epidemiology of venous ulcer
According to Edinburgh study which was a cross-sectional study of a random 
sample, the venous leg ulcers represents an approximate 70% of all leg ulcers and 
estimates 1% of the population with a prevalence that increases with age [22].
Development in diagnosis and early management of varicose vein especially 
with significant reflux can decreased prevalence of venous ulcer by 50% as super-
ficial vein insufficiency represent 50% of causes of leg ulcers. The management of 
risk factors as obesity had great relationship with venous ulcers [23].
On the basis of estimates of the San Diego epidemiologic study, more than 11 
million of men and 22 million of women between the ages of 40 and 80 years in the 
United States have varicose veins, as well as more than two millions of adults have 
advanced CVD with skin changes or ulcers [24].The incidence of post-thrombotic 
venous ulcers has not changed in the past two decades for women and it recently 
increases in men [25].
6. Clinical presentation and diagnosis of CVI and venous ulcer
There is a wide spectrum of differential diagnosis for ulcer in lower limb. 
Therefore, the proper management depends on determine the etiology of ulcer and 
mange it. Venous ulcer constitutes the most common cause of lower limb ulcers 
followed by arterial & diabetic ulcer. There are distinctive clinical presentation and 
physical examination findings which can help to differentiate venous ulcers from 
other lower extremity disorder [26].
The diagnosis of venous ulcers is generally clinical; this step in diagnosis of 
venous ulcer is neglected by physicians and they are based on radiology report only 
as color duplex ultrasonography and venography that may be helpful in doubtful 
cases [27].
Inspection and palpation are essential parts of the examination and should be 
searched on signs of venous disorder, auscultation for bruit is particularly helpful 
in those with vascular malformation and arteriovenous fistula [27]. Examination 
always done with patient in a standing position and should focus on size and 
distribution of varicose veins.
Wound Healing
8
Specific signs for CVI:
Eklof and his team have defined signs presents in the clinical part of CEAP clas-
sification that suggested CVI (Figures 5–7) [21]:
Lower limb edema: the edema of venous hypertension unilateral, start at ankle, 
pitting pattern and becomes more worse at evening.
Eczema: Erythematous dermatitis, that is usually distribute on varicose vein 
a result of uncontrolled CVD, but can be seen anywhere in response to local 
management.
Skin pigmentation: extravasated blood due to venous hypertension in small vein 
leads to accumulation of hemosiderin intradermal that the causes behind Brownish 
darkening of skin around ankle region and sometime leg.
Lipodermatosclerosis (LDS): defined by Eklof as a localized chronic inflam-
mation with fibrosis in skin and subcutaneous tissue and may progress to scaring 
& contracture in tendo Achilles [21]. Most of author agree that LDS is highly 
suggestive of sever CVI and gives clue about bad prognosis of wound healing. LDS 
frequently proceed the development of venous ulcer in a lot of cases [18].
Atrophie blanche (white atrophy): smooth white atrophic plaque surrounded by 
dilated capillary and hyperpigmentation some times. It is also sign of sever CVI and 
should be distinguished from healed ulcers by history as develop independently. 
Ulcerated atrophie blanche can be extremely painful and have low tendency for 
healing [18].
Venous ulcer: Gillespie mentioned the most current updated definition for 
venous ulcer as (a full thickness defect of the skin, located in the lower leg, typically with 












history of DVT, documented axial venous reflux or deep vein obstruction) in absence of 
another condition that could be the essential cause of the ulcer) [28].
Positive history of previous DVT event, family history of varicose vein or 
previous intervention to venous system in line with good clinical examination help 
to clarify the diagnosis in up to 76% of cases of venous ulcer [18]. the choice of 
investigation should be based on severity of problem and management plan, It is 
usually use the non-invasive method to evaluate patient for venous ablation or pre-
operative surgery to perforator and keep invasive diagnostic method to patient need 
complex operation such as valve reconstruction or venous bypass [12].
The palpable pedal pulse or measurement of ankle-to-brachial blood pressure 
ratio (ankle/brachial index [ABI]) is one of the critical points in diagnosis of venous 
ulcer as differentiate it from arterial ulcer and determine if there is any association 
of ischemic degree that contraindicated to compression therapy, the traditional 
management to venous ulcer. The culture swab and investigations for vasculitis 
and connective tissue diseases such as rheumatoid arthritis helpful in diagnosis of 
despiteful cases and resistant ulcer [18].
The atypical appearance of ulcer as nodular growth, everted edges, deterioration 
or delay healing with appropriate treatment are indications for biopsy tacking from 
ulcer to exclude malignant transformation [29].
Duplex scan is currently the golden standard for evaluation of patient with 
CVI, with high sensitivity & specificity in diagnosis of superficial and deep venous 
system disorders, it gives information about patency of deep venous system, 
diameter of vein and flow rate. The real time color duplex scan makes orientation 
of venous flow much easier and provides information about reflux in superficial, 
deep or perforator vein, through interpretation all previous dates the differentiation 
between primary and secondary CVI be easy. In addition, duplex scan today had an 
important role in endovenous procedure [23].
Phlebography such as ascending or descending phlebography are not diagnostic 
tools of first choice in case of venous ulcer and preserved for evaluation of venous 
system before complex procedure as valve reconstruction or bypass as it can provide 
information about level of obstruction in deep venous system and state of valves [23].
CT Angiogram useful tool for assessment of pelvic vein and inferior vena cava 
(IVC) especially before venous stenting, MR Venogram preferred to vein malforma-
tion cases.
7. Management of venous ulcer
The management of chronic venous ulcer constitutes one of the most major 
heath challenge on side of healing, prevent recurrence and minimize social and 
economic effect. In western world, approximately 1% of annual health care bal-
ance expended on venous ulcer care [22]. The future world vision directed toward 
the prevention of incidence of venous ulcer more than their management that 
becomes more expensive through time, that is standing on goal of Pacific Vascular 
Symposium 2009 that talked on globally decrease incidence of venous ulcer by 50% 
in next 10 years [30].
The key for management of venous ulcer is reduced ambulatory venous hyper-
tension (AVH) that leads to decrease of edema and inflammatory reaction in leg 
result in stimulate healing of ulcer and prevents recurrence if maintained optimum 
venous pressure. The correction of vein disorder that leads to venous hyperten-
sion is an important step beside ulcer care [31]. The management of venous ulcer 




care) and surgical part (surgical cover of ulcer and surgical elimination of venous 
hypertension).
7.1 Conservative management
7.1.1 Modification of life style
Theoretically moderate exercise concentrated on mobility of ankle joint and 
contraction of calf muscle (peripheral heart) thought to be benefit in decrease 
venous congestion of lower limb and hemodynamics, despite there is no enough 
study about the effect of exercise on healing of venous ulcer but supervised mod-
erate exercise should be considered as adjuvant to main treatment for CVI and 
venous ulcer.
Another important procedure that not allows very practical for patient is leg 
elevation at or above the level of heart that can be decrease venous pressure around 
the ankle nearly to zero resulting in an improve of lower limb swelling and increase 
ulcer healing rate. Leg elevation if associated with compression therapy can be 
decrease ulcer recurrence [31].
7.1.2 Compression therapy
Compression therapy still the corner stone of CVI and venous ulcer care. It is 
defined as an applied external pressure on specific lower limb area to overcome the 
gravity and hydrostatic pressure in vein. The mechanism of act is not fully understood 
until now. It depends on preserve interfacing pressure and stiffness (increase of inter-
face pressure with activity as increased limb circumference by muscle contraction).
In normal standing patient application an external pressure of 35–40 mmHg will 
narrow the vein but if pressure excessed 60 mmHg it will lead to occluding of vein, 
so optimum external graduated pressure between 35 and 40 mmHg will improve 
venous pumping function and microcirculation. In addition, it is lowering the level 
of inflammatory mediator as alpha tumor necrosis factor which cause tissue dam-
age. Therefore promotes ulcer healing [31].
The Unna boot was the oldest modality of compression therapy that has devel-
oped since 1885. Other modality that be more familiar now are compressive ban-
dages, compression stockings and intermittent pneumatic device. The LaPlace’s law 
states that the pressure in cylinder inversely related to radius with uniform tension 
on wall, so this modality of compression will provide graduated pressure that the 
highest at ankle resulting in cephalic direction of venous flow [32].
The recent Cochrane review found that the venous ulcer heals rapidly with 
application of compression therapy than without and high graded compression by 3 
or 4 layer bandage or short stretch bandage better than other system that deliver low 
pressure [33].
High graded compression (sub bandage pressure 35–40 mmHg at ankle) by stan-
dardized four layer bandage technique that used in UK show shorter time needed 
for healing than short stretch bandage in meta-analysis of randomized trial [34] . 
With average healing rate approximate 60–70% at 12 to 24 weeks by various type of 
compression model [35].
The Brien et al. stated that the four layer bandaging is the most effective 
method for management of venous ulcer with healing rate 54% at three months in 
randomized control trial that conducted on 200 patients. In addition, he recom-
mend to use it routinely in management of patient with uncomplicated venous 
ulcer. Also it can be decrease rate of recurrence if maintained lifelong [36].
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According to recommendation of SIGN guidelines (Scottish Intercollegiate 
Guidelines Network) [37] & International Leg Ulcer Advisory Board the technique 
and component of these system that also known as Charing Cross Hospital Bandage 
include (Figure 8) [38].
First layer: (padding layer) orthopedic cotton role applied in spiral fashion 
with minimal overlap from base of toes to just under the knee to protect the bony 
prominence and absorb exudate, in patient with ankle circumference less than 
18 cm additional layer needed as artificial increase of circumference.
Second layer: (cotton crepe bandage) that over smooths the first layer and has 
the last effect in compression, applied in spiral fashion with 50% overlap.
Third layer: elastic extensible bandage applied by figure of eight winding with 
50% extension from base of toes to just under the knee (It provide sub bandage 
pressure = 17 mmHg). The ankle joint kept in dorsiflexion or at 90° angle.
Fourth layer: elastic cohesive bandage, it’s 2nd layer of compression, applied in 
spiral fashion with 50% overlap & 50% extension (adds remaining =23 mmHg sub 
bandage pressure) (Figure 9).
The disadvantages of the four -layers compression bandage is that they need 
trained physician to apply the optimum pressure in against to compression stock-
ings that self-used and can be removed at night [39].
The intermittent pneumatic compression is an expensive and requires immobi-
lization of the patient. Therefore, it is reserved for bedridden patients who cannot 
tolerate continuous compression therapy [40].
7.1.3 Ulcer care
We can use the tap water for cleaning venous ulcer. There is no advantage 
observed by use of physiological saline and recommended to deep debridement  
for recalcitrant chronic venous leg ulcers to remove fibrosis that arrest  
healing process, but use of chemical or enzymatic debridement have no special 
advantage [23].
A meta-analysis of 42 randomized controlled trials have showed no major dif-
ference between dressing types and the expensive hydrocolloid dressings. it is not 
getting high medical evidence support use it as a healing benefit over the lower-cost 
simple nonadherent dressings. Without clear evidence that support the use of dress-
ing type over another, the choice of dressings for venous ulcers can be directed by 
cost, ease of application, patient and physician preference [41].
Figure 8. 
Component of four-layer bandaging. 1. Orthopedic cotton role; 2. cotton crepe bandage; 3. elastic extensible 




There is no evidence support that the use of topical antibiotic has positive effect 
on management of infected venous ulcers or promote healing, A Cochrane review 
on use of silver containing topical material concluded that there is no insufficient 
evidence to support use it in infected venous ulcers. Other articles support to avoid 
topical application as it sensitize the skin, as well as a recommendation to manage 
clinical infected venous ulcer by the use of systemic antibiotics [29].
7.2 Surgical management
7.2.1 Surgical cover of ulcer (skin graft)
skin grafting may be used for patients with large or refractory venous ulcers that 
does not show sign of healing within4–6 weeks with stander care [29]. However, 
skin grafting is not effective if there is persistent edema, which is common with 
venous insufficiency, and the underlying venous disease is not addressed. A recent 
Figure 9. 
Four-layer compression bandaging steps.
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Cochrane review found few high-quality studies to support the use of skin grafting 
for the treatment of venous ulcers [42].
7.2.2 Surgery for venous insufficiency
The role of surgery is to reduce venous hypertension, promote healing, and 
prevent ulcer recurrence. Surgical options for treatment of venous insufficiency 
include ablation of the saphenous vein; interruption of the perforating veins with 
sub-fascial endoscopic surgery; stenting of iliac vein obstruction and removal of 
incompetent superficial veins with phlebectomy, stripping, sclerotherapy or laser 
therapy [43].
Scottish guidelines stated that there is no evidence to support the surgical 
intervention for venous insufficiency should be prior to stander management 
(compression) for healing of venous ulcer and the available study showed signifi-
cant difference in recurrence in favor for surgery [23].
7.3 Platelet concentrates
Platelet concentrates are autologous material prepared from venous blood after 
various processing of blood samples. Generally, it depend on centrifugation prin-
ciple to separate the whole blood sample into red blood cells that heavy so precipi-
tated down and concentrate other element that can be used by topical or infiltration 
for therapeutic purposes [44].
Platelet concentrates that first has presented since 20 years ago and it was devel-
oped on aim of using blood protein elements as a biological source of growth factors 
that able to promote the angiogenesis process and stimulation of cells involved in 
healing process as fibroblast, neutrophils and mesenchymal stem cells [45].
Platelet Rich Fibrin: This is a natural fibrin matrix that developed by 
Choukroun’s et al. In France, through new technology that characterized by simple 
and open access technique without anticoagulant or bovine thrombin. Just immedi-
ate centrifugation of patients’ blood sample that lead to conversion of fibrinogen to 
fibrin by physiological thrombin, this slow polymerization of fibrin charged it by 
platelets, leucocytes and cytokines to give us autologous biomaterial from platelets 
and immune cells support healing of process [46].
The protocol for prepare of PRF is very simple: blood extracted from patient in 
glass coated tube without anticoagulant and immediate centrifuged and here time 
factor is so important as coagulation cascade started within minutes by activa-
tion of platelets through contact with glass tube in absent of anticoagulant then 
physiological thrombin transform the fibrinogen to fibrin net-work charged with 
active platelets and cytokines that will take the middle portion of tube between the 
precipitated red blood cells layer in bottom by effect of centrifuge device and acel-
lular plasma in top [47]. Any delay in blood handling will lead to start coagulation 
without separation of blood component and fibrin will be formed in diffuse way in 
all of tube result in blood clot not PRF clot (Figures 10–12) [48].
From clinical date note the ability of PRF to induce healing without any inflam-
matory excess. Dohan et al. stated the PRF process not only activate the platelet but 
also leucocytes to release important cytokines in response to artificial inflammation 
induced by these technique. Initial investigation revealed the PRF working also as 
immune node for increase defense mechanism and control inflammatory response 
that explain the decrease of surgical site infection which treated by PRF due to 
effect of trapped cytokines in fibrine net-work [49].
The PRF contains three main components that are important to tissue healing. 




between PRF and previous generation PRP as PRF is not only platelets, but it’s also 
incorporate active leucocytes that had a role in anti-infection and regulation of 
immunity, natural three dimension fibrin net-work is second component which 
Figure 10. 
Centrifuge device that used for PRF.
Figure 11. 




a male patient, 45 years old, with secondary CVI at left leg with two ulcers treated by four layer compression 
bandages and PRF membrane applied on proximal ulcer only.
Figure 12. 
PRF membranes on the surface of ulcer.
Figure 14. 





not work as server for host cells only but had the ability to promote cell invasion 
and helped in tissue regeneration. The last iteam in these structure is the natural 
growth factors that had an important biological role in healing process as PDGF 
is an essential growth factor for cell migration, differentiation and proliferation, 
also VEGF which is important for angiogenesis process in granulation tissue, other 
growth factors as TGF-beta, epidermal growth factor and insulin-like growth factor 
that are important to wound healing (Figures 13 and 14) [45, 50].
Yazawa et al. stated that the concentration of growth factors in PRF three 
times more than in platelet-rich plasma (PRP) due to use of fibrine as drug delivery 
system for growth factors, more over it help in slow release of that natural factors 
over a period of one week approximately [51].
8. Conclusion
• Venous ulcers are the most common cause of chronic leg ulcers with high 
impact on patients’ quality of life and productive work time.
• The management depends on reversing the ambulatory venous hypertension 
which is the essential pathological factor behind the VLUs by using the com-
pression therapy the corner stone of management along with new adjuvant 
therapies that able to provide necessary growth factors to promote healing 
process.
• Platelet-rich fibrin (PRF) is promising material for wound healing as the plate-
lets and leukocytes release many growth factors and cytokines that important 
for wound healing.
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